The Most Notable Longevity Startups of 2022

In 2022, a number of startups made headlines in the rejuvenation/longevity industry by conducting groundbreaking research or publishing notable progress about the longevity ecosystem. Let’s take a look at the most notable names in the industry as we wrap up the year. 

1. Altos Lab- Rejuvenation Biotech

Jeff Bezos is the founder of Altos Lab, a rejuvenation biotech start-up that focuses on leveraging biological reprogramming. This kind of technology analyzes rejuvenating cells in a laboratory environment, and then builds on that technology to revitalize tissues, organs, and the entire human body. 

There is a lot of promise from previous studies on rejuvenating mice that we could wind back the clock in human beings as well. In light of this, Altos is looking to establish several institutes of rejuvenation in places such as the Bay Area and San Diego in the US, Japan, and Cambridge in the UK. 

The primary investors of Altos include Jeff Bezos, venture capitalist Yuri Milner together with his wife. So far, it is estimated that the startup has secured over $3 billion in funding from the trio, as well as other global backers. 

2. Arda Therapeutics- Cell targeting to Combat Disease

This biotech startup was founded by Dr. Adam Freund in the San Francisco Bay Area. It focuses on using single-cell data from patients to identify target cells that can be removed to tackle a number of aging-related diseases. Several diseases are caused by an excess of pathological cell types. The company’s research focuses on the elimination of entire pathological networks, or the entire cell.

Arda Therapeutics has, therefore, invented an approach that respects the systems nature of biology, utilizes the full value of single-cell data, and increases therapeutic options by selecting targets from the cell surface proteome.

The company has received funding from venture capital firms such as Andreessen Horowitz, Village Global, GW, and The Longevity Fund, amongst other participants. 

3. Oviva Therapeutics- Focusing on Ovarian Physiology

This startup’s objective is focused on the vast potential in women’s health by spearheading research and clinical development by targeting ovarian physiology, and by improving funding and awareness in this space. 

The startup targets age-related decline in ovarian function, which can translate to serious health outcomes in women. The company is looking to extend health span in women by creating novel therapeutics that focus on ovarian function and longevity. 

4. Modern Age- Controlling the aging journey

Modern Age was founded earlier this year by former vice president at Amazon and COO at Glossier, Melissa Eamer. The startup focuses on combining digital tools such as telehealth, together with in-person treatments, at its flagship studio located in New York City. 

The company focuses on providing digital assessments to users based on their different features to determine how old they feel, and then provides a set of personalized recommendations such as treatments, prescriptions, and products. The startup plans to initially focus on the areas of hormone health, bones, and skin; which Eamer believes are some of the primary areas where people begin to notice the signs of aging. So far, the company has received about $27 million in its first round of funding.